These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 6762533)
21. Comparison of clonidine and methyldopa in hypertensive patients receiving a diuretic. A double-blind crossover study. Mroczek WJ; Leibel BA; Finnerty FA Am J Cardiol; 1972 May; 29(5):712-7. PubMed ID: 4553738 [No Abstract] [Full Text] [Related]
22. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa. Malini PL; Strocchi E; Ambrosioni E; Magnani B Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071 [TBL] [Abstract][Full Text] [Related]
23. Comparative antihypertensive effects of guanabenz and methyldopa. Walker BR; Deitch MW; Schneider BE; Hare LE Clin Ther; 1981; 4(4):275-84. PubMed ID: 7332915 [TBL] [Abstract][Full Text] [Related]
24. Double-blind trial comparing guanfacine and methyldopa in patients with essential hypertension. Bune AJ; Chalmers JP; Graham JR; Howe PR; West MJ; Wing LM Eur J Clin Pharmacol; 1981; 19(5):309-15. PubMed ID: 7016550 [No Abstract] [Full Text] [Related]
25. [Therapy of hypertension with Leron (cyclacenin) and Tadip (cyclacenin and alpha-methyldopa)]. Stampfer E Wien Med Wochenschr; 1968 Jun; 118(24):551-4. PubMed ID: 5711781 [No Abstract] [Full Text] [Related]
26. [The broad-spectrum antihypertensive agent Tadip in slight and moderate hypertension]. Kempf E Med Monatsschr; 1968 Jun; 22(6):270-5. PubMed ID: 5720912 [No Abstract] [Full Text] [Related]
27. Comparison of the effects of guanadrel sulfate and propranolol on blood pressure, functional capacity, serum lipoproteins and glucose in systemic hypertension. Darga LL; Hakim MJ; Lucas CP; Franklin BA Am J Cardiol; 1991 Mar; 67(7):590-6. PubMed ID: 2000792 [TBL] [Abstract][Full Text] [Related]
28. [Therapeutic trials with the new antihypertensive agent Tadip]. Stein G Med Klin; 1968 Sep; 63(37):1466-8. PubMed ID: 5730203 [No Abstract] [Full Text] [Related]
29. [Double-blind assay of a new hypotensive agent of central action, guanfacine, compared with alpha-methyldopa]. Jiménez Casado M; Canto J; Yapur H; Oller JM Rev Clin Esp; 1984 Jul 15-31; 174(1-2):41-4. PubMed ID: 6393236 [No Abstract] [Full Text] [Related]
30. The drug treatment of hypertension. Bulpitt CJ; Dollery CT Practitioner; 1971 Jul; 207(237):43-51. PubMed ID: 4397593 [No Abstract] [Full Text] [Related]
32. Ketanserin in mild to moderate hypertension in the elderly: a double-blind study versus methyldopa. Cattin L; Da Col PG Clin Ther; 1989; 11(3):363-72. PubMed ID: 2663164 [TBL] [Abstract][Full Text] [Related]
33. [Hypotensive drugs]. Cybulska I Pol Arch Med Wewn; 1979 Nov; 62(5):437-47. PubMed ID: 43505 [No Abstract] [Full Text] [Related]
35. [Guanfacine (Estulic) in the monotherapy of essential hypertension, grades I and II, according to WHO]. Mayer K; Lupínek Z; Janousek S; Podrouzková B Cas Lek Cesk; 1984 Oct; 123(43):1306-11. PubMed ID: 6391673 [No Abstract] [Full Text] [Related]
36. Double-blind comparator trials with pinacidil, a potassium channel opener. Callaghan JT; Goldberg MR; Brunelle R Drugs; 1988; 36 Suppl 7():77-82. PubMed ID: 3076139 [TBL] [Abstract][Full Text] [Related]
37. Sympathetic nervous function and renin activity in hypertensives on long term drug treatment with propranolol, methyldopa or bendrofluazide. Polak G; Reid JL; Hamilton CA; Jones DH; Dollery CT Clin Exp Hypertens (1978); 1978; 1(1):1-9. PubMed ID: 755641 [TBL] [Abstract][Full Text] [Related]
38. Long term comparative study of guanfacine and alpha-methyldopa in essential hypertension. Rengo F; Ricciardelli B; Volpe M; Trimarco B; Saccà L; Condorelli M Arch Int Pharmacodyn Ther; 1980 Apr; 244(2):281-91. PubMed ID: 6996627 [TBL] [Abstract][Full Text] [Related]
39. [Antihypertensive activity of a new molecule, 2,6-dichloro-benzylidene aminoguanidine acetate]. Chiummo R Minerva Med; 1975 Dec; 66(84):4546-50. PubMed ID: 1202408 [TBL] [Abstract][Full Text] [Related]